Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects

Dihydroartemisinin-piperaquine is an artemisinin-based combination treatment (ACT) recommended by the WHO for uncomplicated Plasmodium falciparum malaria, and it is being used increasingly for resistant vivax malaria where combination with primaquine is required for radical cure. The WHO recently re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanboonkunupakarn, Borimas, Ashley, Elizabeth A., Jittamala, Podjanee, Tarning, Joel, Pukrittayakamee, Sasithon, Hanpithakpong, Warunee, Chotsiri, Palang, Wattanakul, Thanaporn, Panapipat, Salwaluk, Lee, Sue J., Day, Nicholas P. J., White, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2014
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249579/
https://www.ncbi.nlm.nih.gov/pubmed/25267661
http://dx.doi.org/10.1128/AAC.03704-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249579/
https://www.ncbi.nlm.nih.gov/pubmed/25267661
http://dx.doi.org/10.1128/AAC.03704-14

Ejemplares similares